A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
Novartis
Debiopharm International SA
AstraZeneca
Servier
Nuvation Bio Inc.
Neonc Technologies, Inc.
Exelixis
Jazz Pharmaceuticals
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Alaunos Therapeutics
Orbus Therapeutics, Inc.
BioMimetix JV, LLC
Bayer
Dawonmedax Co., Ltd.
Rigel Pharmaceuticals
BeiGene
Taproot Health
Oblato, Inc.
Servier
Everfront Biotech Co., Ltd.
Celgene
Istari Oncology, Inc.
Candel Therapeutics, Inc.
Novartis
Sumitomo Pharma America, Inc.
Candel Therapeutics, Inc.
Candel Therapeutics, Inc.
OncoSynergy, Inc.
TVAX Biomedical
TVAX Biomedical
Vanquish Oncology, Inc.
KIYATEC
CENTOGENE GmbH Rostock
Karyopharm Therapeutics Inc
Quadriga Biosciences, Inc.
Oblato, Inc.
Orbus Therapeutics, Inc.
Biogen
Tocagen Inc.
Tocagen Inc.
Tocagen Inc.
Pfizer
Tocagen Inc.
Tocagen Inc.
Tocagen Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC